iHuman
8 hedge funds and large institutions have $7.97M invested in iHuman in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more funds holding
Funds holding: 7 → 8 (+1)
2% more capital invested
Capital invested by funds: $7.8M → $7.97M (+$176K)
0.01% more ownership
Funds ownership: 2.19% → 2.2% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$12.8K |
| 2 |
Morgan Stanley
New York
|
+$7.84K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$6.38K |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.38K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$560 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$11.5K |
| 2 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$624 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
APA
1
Arisaig Partners (Asia)
Singapore
| $7.79M | – | – | – |
|
|
2
State Street
Boston,
Massachusetts
| $71.8K | +$2.38K | +770 | +3% |
|
|
3
Citadel Advisors
Miami,
Florida
| $43.8K | +$12.8K | +4,146 | +40% |
|
|
4
Renaissance Technologies
New York
| $34K | -$11.5K | -3,735 | -25% |
|
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $27K | +$6.38K | +2,065 | +30% |
|
|
6
Morgan Stanley
New York
| $10.8K | +$7.84K | +2,537 | +244% |
|
|
7
UBS Group
Zurich,
Switzerland
| $547 | +$560 | +181 | New |
|
8
Qube Research & Technologies (QRT)
London,
United Kingdom
| $42 | +$43 | +14 | New |
|
|
NA
9
NewEdge Advisors
New Orleans,
Louisiana
| – | -$624 | -211 | Closed |
|
IH Hedge Fund Activity: Q3 2023 in Review
8 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q3 2023, worth a combined $7.97M — up 2.3% from $7.8M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IH positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $12.8K. The largest seller was Renaissance Technologies, cutting an estimated $11.5K.
- 8 institutional investors held iHuman (IH) as of Q3 2023, up from 7 in Q2 2023.
- Funds reported $7.97M of iHuman stock for Q3 2023, up 2.3% quarter-over-quarter.
- 2 funds opened new iHuman positions in Q3 2023 and 1 closed out, a net change of +1 holder.
- The largest iHuman buyer in Q3 2023 was Citadel Advisors, an estimated $12.8K added.
- The largest iHuman seller in Q3 2023 was Renaissance Technologies, an estimated $11.5K sold.
Based on aggregated 13F filings for Q3 2023.